Wolf Hervé Fridman

Wolf Hervé Fridman is a Scientific Advisor at Parthenon Therapeutics. Wolf was previously a Professor at Centre de Recherche des Cordeliers, INSERMU1138, and Professor of Immunology at Université Paris Descartes. Wolf has been working in the field of immunology for over 30 years.

Fridman was born in Paris, France. Wolf received their medical degree from the Université Paris Descartes in 1986. Wolf then went on to complete their PhD in immunology at the same university in 1989. After completing their PhD, Fridman became a postdoctoral fellow at the National Institutes of Health in the United States.

In 1993, Fridman returned to France to take up a position as a research scientist at INSERM. In 1996, they were appointed Professor of Immunology at Université Paris Descartes. In 2003, they became a Professor at the Centre de Recherche des Cordeliers.

Fridman’s research has focused on the role of the immune system in the development and progression of cancer. Wolf has made significant contributions to our understanding of how the immune system can be harnessed to fight cancer. Wolf's work has led to the development of new immunotherapy treatments for cancer, which are now being used to treat patients with cancer all over the world.

Fridman is a world-renowned expert in immunology and cancer. Wolf has published over 200 scientific papers and is frequently invited to speak at international conferences. Wolf is also a member of the editorial board of several scientific journals.

Wolf Hervé Fridman attended Université Pierre et Marie Curie, where they earned their Docteur es Sciences in 1978-1981. Wolf also attended Université de Paris, where they earned their Docteur en médecine in 1962-1970.

This person works with the Wolf Hervé Fridman team.